U.S. markets closed

United Cannabis Corporation (CNAB)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0165-0.0315 (-65.62%)
At close: 3:59PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0480
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0165 - 0.0439
52 Week Range0.0051 - 0.3690
Avg. Volume947,939
Market Cap1.408M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • Benzinga

      United Cannabis Corporation Obtains Notice Of Allowance For New Patent: 'A Valuable Addition'

      Cannabinoid focused biotechnology company United Cannabis Corporation (OTC: CNAB) said Thursday it has obtained a Notice of Allowance from the United States Patent and Trademark Office for its new patent application that declares procedures of using and preparing cannabinoid formulations. Once the company pays the necessary fees to the USPTO, this application will evolve into an issued patent.